Venus remedies files patent in 48 countries for 2nd PCT application

New Delhi, June 15 (UNI) Chandigarh-based pharmaceutical company Venus Remedies Ltd today said it has filed for Patent in 48 countries for the national phase of its second PCT application for its research product, "Fixed Dose Combination of Latest Generation Cephalosporin with a Beta-Lactamase".

The company had filed the Indian Patent for this broad spectrum antibiotic in 2004 and the PCT in November 2005, a statement said.

It has finalised and filed for Patent Protection of this formulation in 48 countries including the US, European Union, Japan, West Asia, Brazil, Australia and New Zealand.

Worldwide this product has a market size worth more than one.00 billion dollar.

UNI